0104 areas
Chondrogenic differentiation
Cartilage-marker expression (SOX9, aggrecan, type II collagen, COMP) in aging mesenchymal stem cells.
Optimum ReGen Peptides21+
Research use only
All research products on this site, including all peptides, are sold strictly for laboratory and research use only, not for human or animal consumption, diagnostic, or therapeutic use. Our tallow skincare products are topical cosmetics. You must be 21 or older to enter.
Third-party testedHPLC + MSMedford, OR
By entering you confirm you are 21+ and accept these products are for research use only. See our Terms and Disclaimer.
Cartalax Peptide (AED Tripeptide)
Three amino acids, H-Ala-Glu-Asp-OH, lyophilized. Sold in 20mg vials for laboratory research.
$64.00
$8020% off
In stock2-Day Priority Air anywhere in the US
Choose your size
Savings per mg compared with the 20mg size.
1
Secure checkout2-Day Priority Air
Complete the order
Frequently bought together
Supplies and compounds researchers add to this order
Finding add-ons…
Shipping & returns
- 2-Day Priority Air: $13 flat anywhere in the US, or pick up in Medford.
- Tracking is emailed the moment your order ships.
- Research compounds are final sale; see the refund policy.
Lab sheet
Cartalax details
Identity, purity and handling data for this compound, in one place. Tap an identifier to copy it.
Molecular Formula
C12H19N3O8
Molar Mass
333.3 g/mol
CAS Number
85806-95-7
Amino Acids
3
Form
Lyophilized powder
Amino acid sequence
3 residues·Tap a residue
chargedpolarhydrophobicglycine / proline
Full data sheet+
- Purity
- A batch report is not published for this product. Contact ORP before ordering if you need one.
- Synonyms
- Ala-Glu-Asp, AED, alanyl-glutamyl-aspartic acid
- PubChem CID
- 87815447
- Storage (lyophilized)
- -20 °C, sealed, light-protected
For research use only. Not for human consumption.
Overview
About Cartalax
Cartalax is a synthetic tripeptide, Ala-Glu-Asp (AED). It belongs to a family of short peptides, two to four amino acids long, that Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology studies for their effects on gene expression in cell-culture models of aging.
Read moreShow less
It has 3 amino acids (H-Ala-Glu-Asp-OH), a molecular formula of C12H19N3O8, a molar mass of 333.3 g/mol and CAS number 85806-95-7; the full identifiers are in the lab sheet above. ORP supplies it as a lyophilized powder for in vitro and preclinical research only. It is not for human or animal use and is not intended to diagnose, treat, cure, or prevent any disease.
In a 2023 study in Advances in Gerontology, AED was added to human mesenchymal stem cells undergoing replicative aging and increased gene expression and protein synthesis of the chondrogenic differentiation markers SOX9, aggrecan, type II collagen and COMP. A 2020 study in the Bulletin of Experimental Biology and Medicine compared AED with the dipeptide KE in human skin fibroblasts during replicative aging.
In a 2020 study in Molecular Biology Reports, AED, alongside the peptides KED and KE, was tested at nanomolar concentrations on the expression of genes linked to cell aging, including IGF1, FOXO1, TERT and NF-κB, in human mesenchymal stem cell cultures. A 2020 review from the same group lists AED among short peptides studied in neural and immune-cell differentiation.
Almost all published work on AED comes from this one research group and uses cell-culture models, so independent replication is limited. Its closest relative in this catalog is Epithalon, the tetrapeptide Ala-Glu-Asp-Gly (AEDG) from the same research program.
Researchers usually confirm identity against the sequence and a molar mass of about 333 by mass spectrometry, and purity by HPLC. A third-party certificate of analysis is not published here for this product; contact ORP before ordering if your work needs particular identity or purity tests.
Research context
What Cartalax is researched for
The areas where this compound appears in the published research literature.
Methodology
How Cartalax is studied
01Method 1Published AED work uses human mesenchymal stem cell and skin fibroblast cultures, often comparing early and late passages to model replicative aging, with…+
Published AED work uses human mesenchymal stem cell and skin fibroblast cultures, often comparing early and late passages to model replicative aging, with gene-expression and protein-synthesis readouts.
02Method 2Identity is confirmed against the sequence H-Ala-Glu-Asp-OH and its molar mass by mass spectrometry, and purity by HPLC.+
Identity is confirmed against the sequence H-Ala-Glu-Asp-OH and its molar mass by mass spectrometry, and purity by HPLC. Each research protocol sets its own model, controls, concentrations and handling; this listing supplies the compound, not a protocol.
Storage protocols
Cartalax storage and handling
Lyophilized
-20°C
Long-term storage, as supplied
Reconstituted
2-8°C
In solution
Full handling protocol+
Store lyophilized Cartalax at -20°C, sealed and protected from light and moisture. Let the vial reach room temperature before opening so moisture does not condense on the powder.
Reconstituted peptide solutions are commonly held at 2-8°C and divided into single-use aliquots to avoid repeated freeze-thaw cycles. Validate the solvent, concentration and use period for your own protocol.
Ordering & shipping
Buy Cartalax online
Cartalax for sale from Optimum ReGen Peptides, a US research-peptide company with a storefront in Medford, Oregon. It is in stock, priced from $80. Every order ships 2-Day Priority Air, a $13 flat rate anywhere in the US, with tracking, or can be picked up at the store.
Cartalax is supplied as lyophilized powder, for laboratory and research use only, not for human consumption.
FAQ
Cartalax FAQ
What is Cartalax?
Cartalax is the synthetic tripeptide Ala-Glu-Asp (AED), studied in cell-culture research on chondrogenic differentiation and gene expression in aging cells. ORP sells it for laboratory research only.
What is the Cartalax amino acid sequence?
Ala-Glu-Asp, written H-Ala-Glu-Asp-OH or AED: three residues, molecular formula C12H19N3O8, molar mass 333.3 g/mol.
What is the CAS number for Cartalax?
85806-95-7. Its PubChem compound ID is 87815447.
How is Cartalax related to Epithalon?
Both come from the same short-peptide research program. Epithalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG); Cartalax is the tripeptide Ala-Glu-Asp (AED), the same sequence without the final glycine.
What does Cartalax research study?
Mainly gene expression in cell-culture models of aging: chondrogenic markers in mesenchymal stem cells, aging-related genes such as TERT and FOXO1, and skin fibroblast function. All of this is laboratory research in cell cultures.
Who has studied Cartalax?
Most published AED studies come from Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology, so independent replication is limited.
Is this Cartalax third-party tested?
A third-party certificate of analysis is not published for this product. Contact ORP before ordering if your work needs particular identity or purity tests.
How should Cartalax be stored?
Keep the lyophilized powder at -20°C, sealed and protected from light and moisture. Reconstituted solutions are commonly kept at 2-8°C in single-use aliquots; validate the use period for your own protocol.
Is Cartalax for human use?
No. ORP sells Cartalax strictly as a laboratory research compound, not for human or animal consumption, and it is not intended to diagnose, treat, cure, or prevent any disease.
Research library